CE vs SERA · rev $10.28B vs rev $77.0K
Celanese Corporation (CE) versus Sera Prognostics Inc (SERA) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Sera Prognostics Inc (SERA) is a medical devices company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported SERA revenue for 2024-12-31 was $77.0K. Net income was -$32.9M. Revenue was down 74.8% from 2023-12-31 to 2024-12-31. SERA currently screens at market cap $89.1M.
CE currently screens at market cap $5.92B. SERA currently screens at market cap $89.1M.
Not investment advice. Open the CE and SERA stock pages for the full models.
Not investment advice.